Dr. Thomas R. Young appointed CEO of Medibio Limited

MELBOURNE: Medibio Limited has announced the appointment of Dr. Thomas R. Young, M.D. as the Company’s Chief Executive Officer, with effect from 19 September 2022.

Dr. Thomas R. Young is a family physician with more than 40 years of medical experience. He is recognized as an innovator and thought leader in the fields of Consumer Directed Health Care and Behavioral Health.

Medibio Limited is a mental health technology company pioneering the use of objective measures to aid in the early detection and screening of mental health conditions. Through their Corporate Health product, the Company offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market.

Dr. Young was the co-founder of Nview Behavioral Health and currently serves as the Chief medical Officer and board member. Nview is a leader in the provision of digital technology for the behavioral health space. Dr Young currently serves as the medical director for Port of Hope a non-profit substance use disorder clinic.

Dr. Young served for six years as the Medical Director of Idaho Medicaid and Dr. Young was also Chief Clinical / Medical Officer of Idaho Medicare QIO Qualis Health for nine years.

Previously, Dr. Young served as Executive Vice President and Chief Medical Officer at Connextions Health, a Florida-based healthcare technology company that was acquired by Optum Health, a division of United Health Group.

Dr. Young also served as President of Behavioral Imaging Solutions, a technology firm recognized for its application of video imaging for the treatment of children with autism.

The Company’s Non-Executive Director Dr. Matt Mesnik, M.D. said “We are excited to have Dr. Young join Medibio as its CEO. Tom has a tremendous background in healthcare as a provider, administrator, innovator and leader. His background in mental health and mental health assessment, is a tremendous asset toward the continued growth of the Company.”

About the author

Leave a Reply

Your email address will not be published. Required fields are marked *